SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

PHARMACOLOGY 1

» Start this Course
(Practice similar questions for free)
Question:

Large number of patients in medical research centers receive the drug provides information about infrequent or rare adverse effects FDA will approve a new drug application if satisfactory

Author: LEIGHTON DWIGHT OBILLOS



Answer:

Phase III


0 / 5  (0 ratings)

1 answer(s) in total